CLAYTON, Mo., Jan. 6, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, January 30, 2026, at 9:00 a.m. Eastern time, Olin's senior management will review the company's fourth quarter 2025 financial results. Our prepared remarks will be followed by a question-and-answer period. A press release, including financial statements and segment information, will be distributed after the market closes on Thursday, January 29, 2026, together with the associated slides. CONFERENCE CALL ...

Core Viewpoint - Olin Corporation's near-term performance is under pressure due to macroeconomic factors such as weak demand, industry oversupply, and high leverage, which pose risks to growth [1][10]. Group 1: Near-Term Concerns - Olin's chlor-alkali and related chemical businesses are experiencing weak demand and oversupply, negatively impacting pricing and profit margins, particularly for caustic soda [2][10]. - The Epoxy segment is facing challenges from subsidized Asian imports and slow recovery in U.S. markets for construction, automotive, and consumer electronics, leading to increased uncertainty regarding chemical demand recovery [2][10]. - High debt levels are constraining Olin's financial flexibility, with total debt unchanged from the previous year, maintaining elevated leverage and increasing exposure to interest rate fluctuations [3]. Group 2: Winchester Segment Challenges - The Winchester segment is facing pressure from rising metal input costs, especially copper, which is expected to increase further, while retailers are destocking due to slow consumer spending [4][10]. - Olin has implemented production cuts and shifted to a make-to-order model to align output with demand and limit inventory build [4]. Group 3: Long-Term Opportunities - Olin is expected to benefit from ongoing cost-saving initiatives and clean hydrogen tax credits, which will enhance margins and cash flow generation [5][10]. - The Beyond250 cost-savings program aims to deliver $70 million to $90 million in annual savings, focusing on operational efficiencies and manufacturing discipline, with benefits expected to become visible from late 2025 [7]. - Olin is positioned to take advantage of the U.S. Clean Hydrogen Production Tax Credit, which will contribute to improved adjusted EBITDA through its chlor-alkali business [8]. Group 4: Market Performance - Olin's shares have declined by 2% over the past six months, compared to a 14% decline in the industry [9].

Financial Data and Key Metrics Changes - For Q3 2025, the company reported EBITDA of $313 million on net sales of $2.8 billion, with a loss of $38 million or $0.29 per share, reflecting a decrease in sales and EBITDA compared to Q2 2025 [8][14][22] - The loss in Q3 2025 was $26 million higher than in Q2 2025, primarily due to lower average sales prices, especially in PVC resin [14][22] - A non-cash impairment charge of $727 million was recorded for goodwill associated with the North American chlorovinyls business unit [4][11] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment delivered EBITDA of $215 million on $1.1 billion of sales, with sales volumes 6% lower compared to Q2 2025 [16][17] - The Performance and Essential Materials (PEM) segment saw sales of $1.7 billion, down $46 million from Q2 2025, driven by a 4% decline in average sales price [20][21] - HIP's EBITDA margin declined to 20% due to lower sales volume and period-related expenses, while PEM's EBITDA fell to $90 million compared to $297 million in Q3 2024 [17][22] Market Data and Key Metrics Changes - North American residential construction demand has softened in 2025, impacting HIP sales volume, although total sales remained comparable to 2024 [8][9] - The global demand for PEM products, particularly PVC resins, has softened, contributing to a challenging macroeconomic environment [10][21] - The company expects total capital expenditures for 2025 to be approximately $900 million [23] Company Strategy and Development Direction - The company is focused on a three-pillar strategy to improve PEM's performance: enhancing plant reliability, reducing costs, and optimizing the manufacturing footprint [12][26] - The HIP segment aims for long-term organic sales growth of 5%-7% per annum, supported by new product innovations and strategic acquisitions [24][25] - The acquisition of ACI is expected to expand the global compound business and enhance access to new markets [10][20] Management Comments on Operating Environment and Future Outlook - Management remains positive about the long-term growth outlook for HIP despite current affordability challenges in the housing market [9][20] - The company anticipates that the global supply-demand imbalance will improve over the next few years, benefiting both the HIP and PEM segments [34][36] - Management highlighted the importance of addressing operational issues that negatively impacted PEM's EBITDA in 2025, with expectations for improvement in 2026 [27][66] Other Important Information - The company has achieved approximately $115 million towards its 2025 structural savings target of $150 million-$175 million, with plans for an additional $200 million in cost reductions by 2026 [23][98] - Cash and investments as of September 30, 2025, were $2.1 billion, with total debt at $4.7 billion [22] Q&A Session Summary Question: Impact of weakening polyethylene market on Q4 earnings - Management acknowledged a slight weakening in polyethylene prices but expects stable operating efficiency and demand [31][32] Question: Commitment to current business portfolio structure - Management believes in the synergy of the combined business model and expects improvements in the PVC business as market conditions stabilize [33][34] Question: Near and mid-term outlook for PVC - Management indicated ongoing challenges in the chlorovinyl chain but is focused on cost reductions and improving reliability to enhance profitability [39][40] Question: Details on ACI acquisition and its impact - The ACI acquisition is expected to bring strong margins and synergies with existing businesses, enhancing overall profitability [41][42] Question: Revision of HIP guidance and its implications for 2026 - Management noted a shift in product mix and period-related costs affecting guidance but remains optimistic about construction activity in 2026 [46][49] Question: Caustic soda market outlook - The caustic soda market is well supplied, with stable pricing expected [50] Question: Opportunities in PVC compounding and building products - Management sees ongoing opportunities for expansion in both sectors, focusing on synergistic acquisitions [53][55] Question: Period-related expenses in HIP - Management clarified that the $20 million in period-related expenses were non-recurring and primarily administrative [74][75] Question: Operating rates in polyethylene - Management expects operating rates to be slightly lower than industry averages but will adjust based on market conditions [78][79]

Financial Data and Key Metrics Changes - For Q3 2025, the company reported EBITDA of $313 million on net sales of $2.8 billion, with a loss of $38 million or $0.29 per share, reflecting a $26 million increase in loss compared to Q2 2025 primarily due to lower average sales prices, especially in PVC resin [6][16][24] - The company recorded a non-cash impairment charge of $727 million related to goodwill associated with its North American chlorovinyls business unit, which significantly impacted financial results [3][10][16] Business Line Data and Key Metrics Changes - The Housing and Infrastructure Products (HIP) segment delivered EBITDA of $215 million on $1.1 billion of sales, with sales volumes 6% lower compared to Q2 2025, but comparable to Q3 2024 [18][19] - The Performance and Essential Materials (PEM) segment saw sales of $1.7 billion, a decrease of $46 million from Q2 2025, driven by a 4% decline in average sales price, which more than offset a 1% increase in sales volume [21][22][24] Market Data and Key Metrics Changes - North American residential construction demand has softened in 2025, impacting the HIP segment, although sales volumes remained stable compared to 2024 [6][8] - The global demand for PEM products, particularly PVC resins, has softened, contributing to a challenging macroeconomic environment and an extended trough in the chlorovinyl chain [10][24] Company Strategy and Development Direction - The company is focused on a three-pillar strategy to improve PEM's performance: enhancing plant reliability, reducing costs, and optimizing the manufacturing footprint [11][13][29] - The company is committed to long-term growth in the HIP segment, supported by investments in new facilities and acquisitions, such as the ACI acquisition, which will expand its global compound business [9][21][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the long-term growth outlook for the HIP segment despite current affordability challenges in the housing market, citing ongoing investments and a solid pipeline of new products [8][27] - The company anticipates that the global supply-demand imbalance will improve over time, which will positively impact the chlorovinyls business [10][29] Other Important Information - The company expects total capital expenditures for 2025 to be approximately $900 million and has achieved $115 million towards its structural savings target of $150 million to $175 million for 2025 [25][24] - The company has a cash and investments balance of $2.1 billion and total debt of $4.7 billion as of September 30, 2025 [24] Q&A Session Summary Question: How will the weakening polyethylene market affect earnings in Q4? - Management acknowledged a slight weakening in polyethylene prices but expects stable operating efficiency and will strive to create value in that segment [35][36] Question: Is the board committed to the current portfolio structure? - Management believes in the synergy of the combined businesses and expects improvements in the PVC business as market conditions stabilize [38][39] Question: What is the near and mid-term outlook for PVC? - Management noted challenges in the chlorovinyl chain but is focused on cost reductions and improving reliability to return to acceptable financial returns [44][46] Question: Can you provide details on the ACI acquisition? - The ACI business is expected to have good margins and synergies with the existing compounds business, enhancing overall performance [48][49] Question: What are the reasons for the revision to HIP guidance? - The revision was due to a shift in product mix and non-recurring period-related costs, but management remains optimistic about the repair and remodeling segment [53][55] Question: How is the company addressing affordability issues in the housing market? - The company is adjusting its product mix to include more affordable options to meet customer needs [112]

Company Overview - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a prominent U.S. manufacturer of ammunition [4] - The chemical products produced by the company include chlorine, caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid [4] - Winchester, a division of Olin, manufactures and distributes sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition, industrial cartridges, and clay targets [4] Upcoming Financial Results - Olin Corporation will review its second quarter 2025 financial results on July 29, 2025, at 9:00 a.m. Eastern time [1] - A press release with financial statements and segment information will be distributed after the market closes on July 28, 2025 [1] Conference Call Details - U.S. callers can access the conference call toll-free at (877) 883-0383, while Canadian callers can dial (877) 885-0477, and international callers can reach (412) 902-6506 [2] - The call will also be available via a live webcast, with participants encouraged to pre-register [2] - A replay of the conference call will be available for one year on the company's website, with a telephonic replay accessible for 7 days starting at 12:00 p.m. Eastern time [3]

Core Insights - Olin Corporation appointed General Edward Daly as a new director on its Board effective March 5, 2025, and he will serve on the Compensation Committee [1] - General Daly has over 36 years of military experience, with his last role as the 20th Commanding General of the U.S. Army Materiel Command, overseeing a budget exceeding $50 billion [2] - Since retiring, General Daly founded Virtus 9, focusing on U.S. national security, and serves as President of Daly Consulting & Logistics, along with advisory roles in other companies [3] Company Overview - Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a major U.S. manufacturer of ammunition [5] - The chemical products produced by Olin include chlorine, caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid [5] - Winchester, a subsidiary of Olin, manufactures and distributes various types of ammunition, including sporting, law enforcement, and military ammunition [5]